IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0174967.html
   My bibliography  Save this article

Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials

Author

Listed:
  • Jalal Poorolajal
  • Fatemeh Zeraati
  • Ali Reza Soltanian
  • Vida Sheikh
  • Elham Hooshmand
  • Akram Maleki

Abstract

Importance: Increased dietary potassium intake is thought to be associated with low blood pressure (BP). Whether potassium supplementation may be used as an antihypertensive agent is a question that should be answered. Objective: To assess the effect of oral potassium supplementation on blood pressure in patients with primary hypertension. Search methods: We searched Medline, Web of Science, Scopus, Cochrane Central Register of Controlled Trials until October 2016. We also screened reference lists of articles and previous reviews. We applied no language restrictions. Selection criteria: We included randomized placebo-controlled clinical trials addressing the effect of potassium supplementation on primary hypertension for a minimum of 4 weeks. Data collection and analysis: We extracted data on systolic and diastolic BP (SBP and DBP) at the final follow-up. We explored the heterogeneity across studies using Cochran's test and I2 statistic and assessed the probability of publication bias using Begg's and Egger's tests. We reported the mean difference (MD) of SBP and DBP in a random-effects model. Results: We found a total of 9059 articles and included 23 trials with 1213 participants. Compared to placebo, potassium supplementation resulted in modest but significant reductions in both SBP (MD -4.25 mmHg; 95% CI: -5.96 to -2.53; I2 = 41%) and DBP (MD -2.53 mmHg; 95% CI: -4.05 to -1.02; I2 = 65%). According to the change-score analysis, based on 8 out of 23 trials, compared to baseline, the mean changes in SBP (MD -8.89 mmHg; 95% CI: -13.67 to -4.11) and DBP (MD -6.42 mmHg; 95% CI: -10.99 to -1.84) was significantly higher in the intervention group than the control group. Conclusions: Our findings indicated that potassium supplementation is a safe medication with no important adverse effects that has a modest but significant impact BP and may be recommended as an adjuvant antihypertensive agent for patients with essential hypertension.

Suggested Citation

  • Jalal Poorolajal & Fatemeh Zeraati & Ali Reza Soltanian & Vida Sheikh & Elham Hooshmand & Akram Maleki, 2017. "Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-16, April.
    • Handle: RePEc:plo:pone00:0174967
    DOI: 10.1371/journal.pone.0174967
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174967
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0174967&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0174967?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Regina Ewa Wierzejska, 2021. "Dietary Supplements—For Whom? The Current State of Knowledge about the Health Effects of Selected Supplement Use," IJERPH, MDPI, vol. 18(17), pages 1-24, August.
    2. Jalal Poorolajal & Shahla Noornejad, 2021. "Metaplot: A new Stata module for assessing heterogeneity in a meta-analysis," PLOS ONE, Public Library of Science, vol. 16(6), pages 1-12, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0174967. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.